# Levothyroxine sodium

NDC: 87063-083
Generic name: Levothyroxine Sodium
Labeler / Manufacturer: ASCLEMED USA INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201210

FDA application: ANDA212399

## Active ingredients

- LEVOTHYROXINE SODIUM: 25 ug/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"87063-083"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=87063-083
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=42a26f8a-dc67-42e4-abb0-d2602afb1b7d